Cargando…

Influence of liver fibrosis stage on nevirapine plasma concentration in HIV-infected patients with chronic hepatitis C virus

Detalles Bibliográficos
Autores principales:	Dragovic, Gordana, Smith, Colette, Jevtovic, Djordje, Youle, Mike, Back, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071948/ http://dx.doi.org/10.1186/1471-2334-14-S4-O17

Ejemplares similares

Choice of first-line antiretroviral therapy regimen and treatment outcomes for HIV in a middle income compared to a high income country: a cohort study
por: Dragovic, Gordana, et al.
Publicado: (2016)

HIV/AIDS mortality in a south east European country versus a west European country
por: Dragovic, Gordana, et al.
Publicado: (2014)

SIDE effects associated with use of nevirapine in HIV treatment naïve patients with respect to baseline CD4 count
por: Shevkani, Manoj, et al.
Publicado: (2010)

Spectrum of adverse cutaneous eruptions to nevirapine – a cross sectional study
por: Budamakuntla, Leelavathy, et al.
Publicado: (2012)

Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens
por: Bommenel, T, et al.
Publicado: (2010)

Forensic application of phylogenetic analysis – exploration of suspected epidemiological linkage
por: Siljic, Marina, et al.
Publicado: (2014)

Treatment outcomes of first-line antiretroviral therapy in HIV-1-positive patients in Serbia
por: Kušić, Jovana, et al.
Publicado: (2016)

Clinical and genetic determinants of nevirapine plasma trough concentration
por: Giacomelli, Andrea, et al.
Publicado: (2018)

Feasibility of testing and detection of HIV-1 drug resistance in proviral DNA
por: Booth, Clare L, et al.
Publicado: (2014)

Prevalence and concordance of high cardiovascular disease scores in HIV/AIDS patients from Croatia and Serbia with four international algorithms
por: Begovac, Josip, et al.
Publicado: (2014)

Nevirapine Plasma Concentrations Are Associated with Virologic Response and Hepatotoxicity in Chinese Patients with HIV Infection
por: Wang, Jia, et al.
Publicado: (2011)

More virological failure with lamivudine than emtricitabine in efavirenz and nevirapine regimens in the Dutch nationwide HIV Cohort
por: Rokx, Casper, et al.
Publicado: (2014)

HIV therapy in an ageing population — the challenge of polypharmacy
por: Back, DJ
Publicado: (2010)

Concordance between noninvasive assessments of fibrosis in patients with HIV/HIV+HBV infection
por: Dumea, Elena, et al.
Publicado: (2014)

Performance of shear-waves elastography in the non-invasive assessment of liver fibrosis in chronic hepatitis in the Romanian population
por: Stoica, Monica Andreea, et al.
Publicado: (2014)

O057. Altered plasma adipokines concentrations in chronic migraine
por: Rubino, Elisa, et al.
Publicado: (2015)

Plasma insulin concentration is affected by body condition in Icelandic horses
por: Jansson, Anna, et al.
Publicado: (2015)

Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant
por: Scarsi, Kimberly, et al.
Publicado: (2014)

Hepatic cytolysis and Hepatitis E Virus infection in HIV-positive patients
por: Mazeron, Marie-Christine, et al.
Publicado: (2010)

Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals
por: Schipani, Alessandro, et al.
Publicado: (2011)

HIV-Infected Patients as a Model of Aging
por: Toljić, Boško, et al.
Publicado: (2023)

Comparison of Nevirapine Plasma Concentrations between Lead-In and Steady-State Periods in Chinese HIV-Infected Patients
por: Kou, Huijuan, et al.
Publicado: (2013)

Association between social psychological status and efavirenz and nevirapine plasma concentration among HIV patients in Kenya
por: Ngayo, Musa Otieno, et al.
Publicado: (2021)

Tumor necrosis factor alpha – an useful biomarker in a combined predictive model for liver fibrosis staging in patients with chronic HCV infection
por: Munteanu, Daniela-Ioana, et al.
Publicado: (2014)

Early stage chronic kidney disease: a paradigm for diffuse fibrosis and clinical progression
por: Edwards, Nicola C, et al.
Publicado: (2014)

OA01-06 LB. HIV-1 plasma RNA and risk of HIV-1 transmission
por: Lingappa, JR, et al.
Publicado: (2009)

Association between Combination Antiretroviral Therapy and Telomere Length in People Living with Human Immunodeficiency Virus
por: Bukic, Ena, et al.
Publicado: (2023)

Pregnancy and birth in HIV seropositive women - present stage results
por: Mitran, Mihai, et al.
Publicado: (2013)

Co-administration of fluconazole increases nevirapine concentrations in HIV-infected Ugandans
por: Wakeham, Katie, et al.
Publicado: (2010)

Genome-wide association study of nevirapine hypersensitivity in a malawian HIV-infected population
por: Carr, Daniel, et al.
Publicado: (2014)

Cutaneous drug-reactions to nevirapine: study of risk factors in 268 HIV-infected patients
por: Badaoui, L, et al.
Publicado: (2014)

Nevirapine-associated liver toxicity and hypersensitivity reactions in a cohort of HIV-1-infected patients,clinical analysis
por: Jonckheere, Sylvie, et al.
Publicado: (2012)

Raltegravir switch improves hepatitis C transaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals
por: Cevik, Muge, et al.
Publicado: (2012)

Liver fibrosis is strongly associated with an enhanced level of immunosuppressive tryptophan catabolism independently of HCV viremia in ART-treated HIV/HCV co-infected patients
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2014)

Long-term protection of hepatitis B vaccine in HIV-infected patients
por: Biekre, R, et al.
Publicado: (2014)

Adverse Events in a Cohort of HIV Infected Pregnant and Non-Pregnant Women Treated with Nevirapine versus Non-Nevirapine Antiretroviral Medication
por: Aaron, Erika, et al.
Publicado: (2010)

Complement supports progression of HIV and turns neutralising antibodies at low concentration into infection enhancing antibodies
por: Dierich, Manfred P, et al.
Publicado: (2006)

48-week efficacy and safety of transitioning virologically stable HIV-1 patients from nevirapine IR 200 mg BID to nevirapine XR 400 mg QD (TRANxITION)
por: Arastéh, K, et al.
Publicado: (2010)

Role of regulatory T cells in murine model of liver fibrosis resolution
por: Lim, X, et al.
Publicado: (2012)

Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi
por: Dickinson, L, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1ctbrs6qb20hqie8h81gugosn2